SCHEMBL4777477

SCHEMBL4777477

Cc1noc(-c2cc(O)c(O)cc2NS(=O)(=O)c2cccc(Cl)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRB P24530 2/20 0.50
EDNRA P25101 2/20 0.50
SLC40A1 Q9NP59 1/20 0.45
PGR P06401 3/20 0.44
WDR5 P61964 1/20 0.43
PKM P14618 1/20 0.43
ACLY P53396 1/20 0.43
ERBB2 P04626 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
FBP1 P09467 1/20 0.42
PIK3CD O00329 1/20 0.42
PIK3CB P42338 1/20 0.42
MTOR P42345 1/20 0.42
PIK3CG P48736 1/20 0.42
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
KDM1A O60341 1/20 0.41
CCR2 P41597 1/20 0.40
PTPN2 P17706 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781223 0.85 EDNRB (0.48) EDNRBEDNRASLC40A1PGRPKM
SCHEMBL4727594 0.85 PIK3CG (0.41) EDNRAPGRFBP1PIK3CDPIK3CB
SCHEMBL3089179 0.81 SLC40A1 (0.46) EDNRBEDNRASLC40A1PGRWDR5
SCHEMBL4836640 0.74 EDNRA (0.46) EDNRBEDNRASLC40A1PIK3CDPIK3CB
SCHEMBL4793957 0.72 AGTR1 (0.47) PKMMAPT
SCHEMBL4780300 0.71 ALDH1A1 (0.51) EDNRAPKMPIK3CDPIK3CGTP53
SCHEMBL4781870 0.71 PIK3CG (0.40) EDNRBEDNRAPIK3CDPIK3CBMTOR
SCHEMBL30304724 0.71 AXL (0.47) SLC40A1ACLYMAPT
SCHEMBL4780564 0.71 AXL (0.47) SLC40A1ACLYMAPT
SCHEMBL4726823 0.70 MEN1 (0.55) SLC40A1PGRACLYCCR2PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008008374-A2 CCR2 INHIBITORS AND METHODS OF USE THEREOF CHEMOCENTRYX, INC. (US) 2008-01-17 WO claimed
WO-2008008374-A2 CCR2 INHIBITORS AND METHODS OF USE THEREOF CHEMOCENTRYX, INC. (US) 2008-01-17 WO disclosed